申请人:Le Grand Mark Darren
公开号:US20050222118A1
公开(公告)日:2005-10-06
Compounds of formula I
in free or salt form, wherein Ar, X, Y, R
1
, R
2
, R
3
, R
5
, m, n, p and q have the meanings as indicated in the specification, are useful for treating conditions mediated by CCR3. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
公式I的化合物,无论是自由形式还是盐形式,其中Ar、X、Y、R1、R2、R3、R5、m、n、p和q的含义如规范所示,对于治疗由CCR3介导的疾病是有用的。还描述了包含这些化合物的制药组合物和制备这些化合物的过程。